Neuroscience Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Neuroscience market size was valued at USD 27000 million in 2022 and is forecast to a readjusted size of USD 34450 million by 2029 with a CAGR of 3.5% during review period.

Neuroscience research refers to the structure and functions of the nervous system, the mechanisms of neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

This report focus on instruments/equipment, consumables and others used in neuroscience research, the main products include brain and neuroimaging devices, neurological microscopes, electrophysiology devices and others.

Global neuroscience main manufactuers include Siemens Healthineers, GE Healthcare, etc. The top 3 companies hold a share about 18%. North America is the largest market of  neuroscience, with a share about 40%, followed by Europe and Asia-Pacific.In terms of product, whole brain imaging is the largest segment, with a share over 50%. And in terms of application, the largest application is hospitals, followed by academic institutes.

This report is a detailed and comprehensive analysis for global Neuroscience market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Neuroscience market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neuroscience market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neuroscience market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neuroscience market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuroscience
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Neuroscience market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Siemens Healthineers
   GE Healthcare
   Philips
   Canon
   Hitachi
   Medtronic
   Leica Microsystems
   Zeiss
   Nikon
   JEOL Ltd
   Natus Medical
   Nihon Kohden
   NeuroPace Inc
   Shimadzu Corporation
   Compumedics
   Noldus Information Technology
   Plexon
   NeuroNexus
   Phoenix Technology Group

   Instrument and Consumables
   Software
   Others

   Academic Institutes
   Hospital
   Research Institutes
   Others

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the neuroscience market in 2025?

The neuroscience market in 2025 benefits from rapidly advancing technologies, such as AI-driven diagnostics, personalized medicine, and brain-computer interfaces. These innovations open new therapeutic avenues and improve treatment outcomes for a range of neurological disorders, making the field attractive to investors and researchers.

What are the weaknesses of the neuroscience market in 2025?

The market faces challenges related to the high cost of research and development, as well as long approval times for new treatments. There's also a lack of standardized protocols for diagnosing and treating neurological disorders, which can slow market growth and lead to inefficiencies.

What opportunities exist in the neuroscience market in 2025?

The increasing prevalence of neurological disorders like Alzheimer's, Parkinson's, and depression presents significant market opportunities. Additionally, advances in gene therapy, neurostimulation, and regenerative medicine provide new, potentially revolutionary treatments that could transform patient care in the coming years.

What are the threats to the neuroscience market in 2025?

One of the major threats is regulatory hurdles and the complex nature of bringing new neurological treatments to market, which can delay or halt progress. Furthermore, competition from other therapeutic areas and potential ethical concerns around neurotechnology could pose challenges to growth and public acceptance.

What are the political factors influencing the neuroscience market in 2025?

Political factors such as government funding for research and development, healthcare policies, and regulatory frameworks play a significant role in the neuroscience market. In 2025, political stability in key markets and favorable policies promoting innovation in neuroscience can drive growth, while changing healthcare policies and restrictions could create barriers.

How do economic factors affect the neuroscience market in 2025?

Economic factors, such as the availability of funding for neuroscience research, economic recessions, and healthcare spending, will impact the market. In 2025, the growing burden of neurological diseases may increase demand for treatments, but economic constraints could affect healthcare budgets and investments in R&D, slowing progress.

What social factors are influencing the neuroscience market in 2025?

Social factors include the increasing awareness of mental health issues and neurological conditions, as well as the aging population. These factors will drive demand for neuroscience treatments. The stigma surrounding mental health disorders is gradually decreasing, encouraging more people to seek care and contribute to market expansion.

What technological factors are shaping the neuroscience market in 2025?

Technological advancements, such as AI, machine learning, and neuroimaging techniques, are revolutionizing the neuroscience market. Innovations in gene therapy, neurostimulation devices, and wearable brain-monitoring technologies are improving diagnosis and treatment of neurological diseases, creating new opportunities in the market.

What environmental factors impact the neuroscience market in 2025?

Environmental factors are less directly related to the neuroscience market, but increasing awareness about the role of environmental factors (e.g., pollution, toxins) in neurological diseases is gaining traction. Public concerns about the environmental impact of pharmaceuticals and medical devices may also push for more sustainable practices in neuroscience R&D.

What legal factors influence the neuroscience market in 2025?

Legal factors, including intellectual property rights, patents, and regulatory standards, will have a significant impact on the neuroscience market. Stringent regulations for clinical trials and drug approvals, as well as evolving laws regarding data privacy in research, will shape how companies operate and bring new treatments to market in 2025.

What are the suppliers in the neuroscience market in 2025?

Suppliers in the neuroscience market include pharmaceutical companies, biotechnology firms, academic institutions, and medical device manufacturers. These entities provide the necessary raw materials, research insights, and technologies to develop and deliver new treatments and diagnostic tools.

What are the inputs in the neuroscience market in 2025?

Inputs include scientific research, clinical trial data, funding for R&D, regulatory approvals, and technological advancements. These inputs drive innovation and allow for the development of effective therapies and diagnostic methods for neurological disorders.

What are the processes in the neuroscience market in 2025?

Key processes involve drug discovery, clinical testing, regulatory approval, production, and distribution. Research in neurobiology, patient trials, and the application of new technologies like neuroimaging and neurostimulation are central to developing treatments for neurological conditions.

What are the outputs in the neuroscience market in 2025?

Outputs include novel drug treatments, medical devices, diagnostic tools, and therapeutic solutions for neurological disorders such as Alzheimer’s, Parkinson’s, and multiple sclerosis. Market growth also yields increased patient care options and personalized medicine advancements.

What are the customers in the neuroscience market in 2025?

Customers include healthcare providers, hospitals, research institutions, and patients suffering from neurological diseases. Additionally, pharmaceutical companies, biotech firms, and investors seeking new opportunities in neuroscience are also key customers within the market.

What is the threat of new entrants in the neuroscience market in 2025?

The threat of new entrants in the neuroscience market is moderate. While the potential for high returns in the field attracts new players, the substantial capital requirements, complex regulatory approvals, and the need for specialized knowledge and technology create significant barriers to entry.

What is the bargaining power of suppliers in the neuroscience market in 2025?

The bargaining power of suppliers is relatively high. Key suppliers, such as those providing cutting-edge neurotechnology, pharmaceuticals, and research materials, often hold patents or exclusive rights to critical technologies. This gives them leverage in pricing and negotiations with companies in the market.

What is the bargaining power of buyers in the neuroscience market in 2025?

The bargaining power of buyers is moderate. While healthcare providers and patients can choose among different treatment options, the relatively small number of highly specialized therapies for neurological disorders means that patients and hospitals may have limited alternatives for certain conditions.

What is the threat of substitute products or services in the neuroscience market in 2025?

The threat of substitutes is moderate to high. Advances in non-pharmaceutical therapies like neurostimulation, gene therapy, and lifestyle interventions (e.g., cognitive behavioral therapy) could offer alternatives to traditional drug treatments. However, the lack of universally effective substitutes for many neurological disorders keeps the threat from being too high.

What is the intensity of competitive rivalry in the neuroscience market in 2025?

The intensity of competitive rivalry is high. The neuroscience market is highly fragmented with numerous global players vying for market share, ranging from big pharmaceutical companies to small biotech startups. Innovation, clinical trial outcomes, and speed to market significantly influence competition, making the landscape highly competitive.

What are the key upstream factors influencing the neuroscience market in 2025?

Key upstream factors include research and development investments, scientific breakthroughs in neurobiology, and advancements in related technologies such as AI, machine learning, and neuroimaging. The collaboration between academia, biotechnology firms, and pharmaceutical companies is crucial to the flow of innovation into the market.

What is the role of suppliers in the neuroscience market’s upstream?

Suppliers in the upstream of the neuroscience market provide the necessary materials, technologies, and research tools for drug development, diagnostics, and medical devices. These include suppliers of raw materials, biotech reagents, neuroimaging equipment, and genetic sequencing technologies that enable research and clinical trials.

What are the challenges faced by the upstream in the neuroscience market?

Upstream challenges include high research costs, long timelines for drug development, and complex regulatory requirements. Additionally, a shortage of skilled professionals, particularly in specialized fields like neurobiology and neuroinformatics, can slow the pace of innovation and development.

How do funding and investments affect the upstream in the neuroscience market?

Funding and investments are critical upstream drivers, as neuroscience research and development require significant capital. The availability of venture capital, public funding for healthcare research, and private sector investment influences the speed and scope of innovation in the field. Limited funding can delay promising research, while increased investment can accelerate breakthrough treatments.

What regulatory factors impact the upstream of the neuroscience market?

Regulatory factors include stringent guidelines for clinical trials, drug approval processes, and ethical considerations in neuroscience research. Regulatory bodies like the FDA or EMA set the standards for safety, efficacy, and ethical conduct, which can influence the pace at which new discoveries reach the market.

What are the key midstream factors influencing the neuroscience market in 2025?

Midstream factors involve the transition from research and development to product commercialization, including clinical trials, regulatory approvals, and market entry strategies. Collaboration between pharmaceutical companies, biotech firms, and healthcare providers plays a crucial role in bridging the gap between scientific innovation and patient care.

What is the role of manufacturers and distributors in the neuroscience market’s midstream?

Manufacturers and distributors in the midstream ensure that innovative therapies, devices, and diagnostic tools are produced at scale and reach healthcare providers. These players manage the production, packaging, and distribution of neuroscience products, ensuring compliance with regulatory standards and addressing supply chain needs.

What are the challenges faced by the midstream in the neuroscience market?

Challenges include managing the complexities of clinical trial design, long approval processes, and meeting regulatory requirements. Additionally, the production of highly specialized treatments, such as biologics or neurostimulation devices, involves technical difficulties and significant costs. Supply chain disruptions and pricing pressures also present obstacles in the midstream.

How does collaboration between stakeholders impact the midstream of the neuroscience market?

Collaboration between research institutions, biotech firms, pharmaceutical companies, and healthcare providers is crucial in the midstream. Effective partnerships help streamline the clinical trial process, facilitate the sharing of data and resources, and ensure that treatments meet patient needs while complying with regulatory standards.

What role do clinical trials play in the midstream of the neuroscience market?

Clinical trials are a central aspect of the midstream process, serving as the testing ground for new treatments and therapies. These trials provide critical data on the safety and efficacy of products, and successful trials lead to regulatory approvals, which allow therapies to enter the market and reach patients.

What are the key downstream factors influencing the neuroscience market in 2025?

Downstream factors focus on the final delivery of neuroscience products to end users, including healthcare providers, patients, and caregivers. These factors include the commercialization of new therapies, market acceptance, patient access to treatments, and the integration of new technologies into clinical practice.

What is the role of healthcare providers and institutions in the neuroscience market’s downstream?

Healthcare providers and institutions, including hospitals, clinics, and private practices, play a vital role in the downstream by administering treatments, conducting diagnostics, and offering patient care. Their acceptance and adoption of new therapies, based on clinical outcomes and ease of integration, directly influence the success of new products in the market.

What are the challenges faced by the downstream in the neuroscience market?

Challenges include the high cost of treatments, which may limit patient access, and the complex reimbursement processes for innovative therapies. Additionally, the adoption of new therapies can be slow due to regulatory hurdles, concerns about efficacy, and the need for healthcare providers to adapt to new technologies or treatments.

How does patient access to treatments affect the downstream in the neuroscience market?

Patient access to treatments is a critical factor in the downstream. High treatment costs, limited insurance coverage, and geographical barriers can prevent many patients from receiving the care they need. Ensuring equitable access to effective therapies will be a significant challenge in making new neuroscience innovations widely available.

What role does market adoption play in the downstream of the neuroscience market?

Market adoption is crucial for the success of neuroscience products in the downstream. The uptake of new treatments, devices, and diagnostic tools by healthcare professionals and patients depends on factors like proven effectiveness, cost-effectiveness, and ease of use. Strong clinical evidence and patient outcomes will drive faster adoption and broader use of new therapies.

Chapter 1, to describe Neuroscience product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuroscience, with revenue, gross margin and global market share of Neuroscience from 2018 to 2023.
Chapter 3, the Neuroscience competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neuroscience market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuroscience.
Chapter 13, to describe Neuroscience research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Neuroscience
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Neuroscience by Type
       1.3.1 Overview: Global Neuroscience Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Neuroscience Consumption Value Market Share by Type in 2022
       1.3.3 Instrument and Consumables
       1.3.4 Software
       1.3.5 Others
   1.4 Global Neuroscience Market by Application
       1.4.1 Overview: Global Neuroscience Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Academic Institutes
       1.4.3 Hospital
       1.4.4 Research Institutes
       1.4.5 Others
   1.5 Global Neuroscience Market Size & Forecast
   1.6 Global Neuroscience Market Size and Forecast by Region
       1.6.1 Global Neuroscience Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Neuroscience Market Size by Region, (2018-2029)
       1.6.3 North America Neuroscience Market Size and Prospect (2018-2029)
       1.6.4 Europe Neuroscience Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Neuroscience Market Size and Prospect (2018-2029)
       1.6.6 South America Neuroscience Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Neuroscience Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Siemens Healthineers
       2.1.1 Siemens Healthineers Details
       2.1.2 Siemens Healthineers Major Business
       2.1.3 Siemens Healthineers Neuroscience Product and Solutions
       2.1.4 Siemens Healthineers Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Siemens Healthineers Recent Developments and Future Plans
   2.2 GE Healthcare
       2.2.1 GE Healthcare Details
       2.2.2 GE Healthcare Major Business
       2.2.3 GE Healthcare Neuroscience Product and Solutions
       2.2.4 GE Healthcare Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 GE Healthcare Recent Developments and Future Plans
   2.3 Philips
       2.3.1 Philips Details
       2.3.2 Philips Major Business
       2.3.3 Philips Neuroscience Product and Solutions
       2.3.4 Philips Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Philips Recent Developments and Future Plans
   2.4 Canon
       2.4.1 Canon Details
       2.4.2 Canon Major Business
       2.4.3 Canon Neuroscience Product and Solutions
       2.4.4 Canon Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Canon Recent Developments and Future Plans
   2.5 Hitachi
       2.5.1 Hitachi Details
       2.5.2 Hitachi Major Business
       2.5.3 Hitachi Neuroscience Product and Solutions
       2.5.4 Hitachi Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Hitachi Recent Developments and Future Plans
   2.6 Medtronic
       2.6.1 Medtronic Details
       2.6.2 Medtronic Major Business
       2.6.3 Medtronic Neuroscience Product and Solutions
       2.6.4 Medtronic Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Medtronic Recent Developments and Future Plans
   2.7 Leica Microsystems
       2.7.1 Leica Microsystems Details
       2.7.2 Leica Microsystems Major Business
       2.7.3 Leica Microsystems Neuroscience Product and Solutions
       2.7.4 Leica Microsystems Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Leica Microsystems Recent Developments and Future Plans
   2.8 Zeiss
       2.8.1 Zeiss Details
       2.8.2 Zeiss Major Business
       2.8.3 Zeiss Neuroscience Product and Solutions
       2.8.4 Zeiss Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Zeiss Recent Developments and Future Plans
   2.9 Nikon
       2.9.1 Nikon Details
       2.9.2 Nikon Major Business
       2.9.3 Nikon Neuroscience Product and Solutions
       2.9.4 Nikon Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Nikon Recent Developments and Future Plans
   2.10 JEOL Ltd 
       2.10.1 JEOL Ltd Details
       2.10.2 JEOL Ltd Major Business
       2.10.3 JEOL Ltd Neuroscience Product and Solutions
       2.10.4 JEOL Ltd Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 JEOL Ltd Recent Developments and Future Plans
   2.11 Natus Medical
       2.11.1 Natus Medical Details
       2.11.2 Natus Medical Major Business
       2.11.3 Natus Medical Neuroscience Product and Solutions
       2.11.4 Natus Medical Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Natus Medical Recent Developments and Future Plans
   2.12 Nihon Kohden
       2.12.1 Nihon Kohden Details
       2.12.2 Nihon Kohden Major Business
       2.12.3 Nihon Kohden Neuroscience Product and Solutions
       2.12.4 Nihon Kohden Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Nihon Kohden Recent Developments and Future Plans
   2.13 NeuroPace Inc
       2.13.1 NeuroPace Inc Details
       2.13.2 NeuroPace Inc Major Business
       2.13.3 NeuroPace Inc Neuroscience Product and Solutions
       2.13.4 NeuroPace Inc Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 NeuroPace Inc Recent Developments and Future Plans
   2.14 Shimadzu Corporation
       2.14.1 Shimadzu Corporation Details
       2.14.2 Shimadzu Corporation Major Business
       2.14.3 Shimadzu Corporation Neuroscience Product and Solutions
       2.14.4 Shimadzu Corporation Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Shimadzu Corporation Recent Developments and Future Plans
   2.15 Compumedics
       2.15.1 Compumedics Details
       2.15.2 Compumedics Major Business
       2.15.3 Compumedics Neuroscience Product and Solutions
       2.15.4 Compumedics Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 Compumedics Recent Developments and Future Plans
   2.16 Noldus Information Technology
       2.16.1 Noldus Information Technology Details
       2.16.2 Noldus Information Technology Major Business
       2.16.3 Noldus Information Technology Neuroscience Product and Solutions
       2.16.4 Noldus Information Technology Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.16.5 Noldus Information Technology Recent Developments and Future Plans
   2.17 Plexon
       2.17.1 Plexon Details
       2.17.2 Plexon Major Business
       2.17.3 Plexon Neuroscience Product and Solutions
       2.17.4 Plexon Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.17.5 Plexon Recent Developments and Future Plans
   2.18 NeuroNexus
       2.18.1 NeuroNexus Details
       2.18.2 NeuroNexus Major Business
       2.18.3 NeuroNexus Neuroscience Product and Solutions
       2.18.4 NeuroNexus Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.18.5 NeuroNexus Recent Developments and Future Plans
   2.19 Phoenix Technology Group
       2.19.1 Phoenix Technology Group Details
       2.19.2 Phoenix Technology Group Major Business
       2.19.3 Phoenix Technology Group Neuroscience Product and Solutions
       2.19.4 Phoenix Technology Group Neuroscience Revenue, Gross Margin and Market Share (2018-2023)
       2.19.5 Phoenix Technology Group Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Neuroscience Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Neuroscience by Company Revenue
       3.2.2 Top 3 Neuroscience Players Market Share in 2022
       3.2.3 Top 6 Neuroscience Players Market Share in 2022
   3.3 Neuroscience Market: Overall Company Footprint Analysis
       3.3.1 Neuroscience Market: Region Footprint
       3.3.2 Neuroscience Market: Company Product Type Footprint
       3.3.3 Neuroscience Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Neuroscience Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Neuroscience Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Neuroscience Consumption Value Market Share by Application (2018-2023)
   5.2 Global Neuroscience Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Neuroscience Consumption Value by Type (2018-2029)
   6.2 North America Neuroscience Consumption Value by Application (2018-2029)
   6.3 North America Neuroscience Market Size by Country
       6.3.1 North America Neuroscience Consumption Value by Country (2018-2029)
       6.3.2 United States Neuroscience Market Size and Forecast (2018-2029)
       6.3.3 Canada Neuroscience Market Size and Forecast (2018-2029)
       6.3.4 Mexico Neuroscience Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Neuroscience Consumption Value by Type (2018-2029)
   7.2 Europe Neuroscience Consumption Value by Application (2018-2029)
   7.3 Europe Neuroscience Market Size by Country
       7.3.1 Europe Neuroscience Consumption Value by Country (2018-2029)
       7.3.2 Germany Neuroscience Market Size and Forecast (2018-2029)
       7.3.3 France Neuroscience Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Neuroscience Market Size and Forecast (2018-2029)
       7.3.5 Russia Neuroscience Market Size and Forecast (2018-2029)
       7.3.6 Italy Neuroscience Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Neuroscience Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Neuroscience Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Neuroscience Market Size by Region
       8.3.1 Asia-Pacific Neuroscience Consumption Value by Region (2018-2029)
       8.3.2 China Neuroscience Market Size and Forecast (2018-2029)
       8.3.3 Japan Neuroscience Market Size and Forecast (2018-2029)
       8.3.4 South Korea Neuroscience Market Size and Forecast (2018-2029)
       8.3.5 India Neuroscience Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Neuroscience Market Size and Forecast (2018-2029)
       8.3.7 Australia Neuroscience Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Neuroscience Consumption Value by Type (2018-2029)
   9.2 South America Neuroscience Consumption Value by Application (2018-2029)
   9.3 South America Neuroscience Market Size by Country
       9.3.1 South America Neuroscience Consumption Value by Country (2018-2029)
       9.3.2 Brazil Neuroscience Market Size and Forecast (2018-2029)
       9.3.3 Argentina Neuroscience Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Neuroscience Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Neuroscience Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Neuroscience Market Size by Country
       10.3.1 Middle East & Africa Neuroscience Consumption Value by Country (2018-2029)
       10.3.2 Turkey Neuroscience Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Neuroscience Market Size and Forecast (2018-2029)
       10.3.4 UAE Neuroscience Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Neuroscience Market Drivers
   11.2 Neuroscience Market Restraints
   11.3 Neuroscience Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Neuroscience Industry Chain
   12.2 Neuroscience Upstream Analysis
   12.3 Neuroscience Midstream Analysis
   12.4 Neuroscience Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Neuroscience Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Neuroscience Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Neuroscience Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Neuroscience Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Siemens Healthineers Company Information, Head Office, and Major Competitors
   Table 6. Siemens Healthineers Major Business
   Table 7. Siemens Healthineers Neuroscience Product and Solutions
   Table 8. Siemens Healthineers Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Siemens Healthineers Recent Developments and Future Plans
   Table 10. GE Healthcare Company Information, Head Office, and Major Competitors
   Table 11. GE Healthcare Major Business
   Table 12. GE Healthcare Neuroscience Product and Solutions
   Table 13. GE Healthcare Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. GE Healthcare Recent Developments and Future Plans
   Table 15. Philips Company Information, Head Office, and Major Competitors
   Table 16. Philips Major Business
   Table 17. Philips Neuroscience Product and Solutions
   Table 18. Philips Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Philips Recent Developments and Future Plans
   Table 20. Canon Company Information, Head Office, and Major Competitors
   Table 21. Canon Major Business
   Table 22. Canon Neuroscience Product and Solutions
   Table 23. Canon Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Canon Recent Developments and Future Plans
   Table 25. Hitachi Company Information, Head Office, and Major Competitors
   Table 26. Hitachi Major Business
   Table 27. Hitachi Neuroscience Product and Solutions
   Table 28. Hitachi Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Hitachi Recent Developments and Future Plans
   Table 30. Medtronic Company Information, Head Office, and Major Competitors
   Table 31. Medtronic Major Business
   Table 32. Medtronic Neuroscience Product and Solutions
   Table 33. Medtronic Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Medtronic Recent Developments and Future Plans
   Table 35. Leica Microsystems Company Information, Head Office, and Major Competitors
   Table 36. Leica Microsystems Major Business
   Table 37. Leica Microsystems Neuroscience Product and Solutions
   Table 38. Leica Microsystems Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Leica Microsystems Recent Developments and Future Plans
   Table 40. Zeiss Company Information, Head Office, and Major Competitors
   Table 41. Zeiss Major Business
   Table 42. Zeiss Neuroscience Product and Solutions
   Table 43. Zeiss Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Zeiss Recent Developments and Future Plans
   Table 45. Nikon Company Information, Head Office, and Major Competitors
   Table 46. Nikon Major Business
   Table 47. Nikon Neuroscience Product and Solutions
   Table 48. Nikon Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Nikon Recent Developments and Future Plans
   Table 50. JEOL Ltd Company Information, Head Office, and Major Competitors
   Table 51. JEOL Ltd Major Business
   Table 52. JEOL Ltd Neuroscience Product and Solutions
   Table 53. JEOL Ltd Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. JEOL Ltd Recent Developments and Future Plans
   Table 55. Natus Medical Company Information, Head Office, and Major Competitors
   Table 56. Natus Medical Major Business
   Table 57. Natus Medical Neuroscience Product and Solutions
   Table 58. Natus Medical Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Natus Medical Recent Developments and Future Plans
   Table 60. Nihon Kohden Company Information, Head Office, and Major Competitors
   Table 61. Nihon Kohden Major Business
   Table 62. Nihon Kohden Neuroscience Product and Solutions
   Table 63. Nihon Kohden Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Nihon Kohden Recent Developments and Future Plans
   Table 65. NeuroPace Inc Company Information, Head Office, and Major Competitors
   Table 66. NeuroPace Inc Major Business
   Table 67. NeuroPace Inc Neuroscience Product and Solutions
   Table 68. NeuroPace Inc Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 69. NeuroPace Inc Recent Developments and Future Plans
   Table 70. Shimadzu Corporation Company Information, Head Office, and Major Competitors
   Table 71. Shimadzu Corporation Major Business
   Table 72. Shimadzu Corporation Neuroscience Product and Solutions
   Table 73. Shimadzu Corporation Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 74. Shimadzu Corporation Recent Developments and Future Plans
   Table 75. Compumedics Company Information, Head Office, and Major Competitors
   Table 76. Compumedics Major Business
   Table 77. Compumedics Neuroscience Product and Solutions
   Table 78. Compumedics Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 79. Compumedics Recent Developments and Future Plans
   Table 80. Noldus Information Technology Company Information, Head Office, and Major Competitors
   Table 81. Noldus Information Technology Major Business
   Table 82. Noldus Information Technology Neuroscience Product and Solutions
   Table 83. Noldus Information Technology Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 84. Noldus Information Technology Recent Developments and Future Plans
   Table 85. Plexon Company Information, Head Office, and Major Competitors
   Table 86. Plexon Major Business
   Table 87. Plexon Neuroscience Product and Solutions
   Table 88. Plexon Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 89. Plexon Recent Developments and Future Plans
   Table 90. NeuroNexus Company Information, Head Office, and Major Competitors
   Table 91. NeuroNexus Major Business
   Table 92. NeuroNexus Neuroscience Product and Solutions
   Table 93. NeuroNexus Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 94. NeuroNexus Recent Developments and Future Plans
   Table 95. Phoenix Technology Group Company Information, Head Office, and Major Competitors
   Table 96. Phoenix Technology Group Major Business
   Table 97. Phoenix Technology Group Neuroscience Product and Solutions
   Table 98. Phoenix Technology Group Neuroscience Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 99. Phoenix Technology Group Recent Developments and Future Plans
   Table 100. Global Neuroscience Revenue (USD Million) by Players (2018-2023)
   Table 101. Global Neuroscience Revenue Share by Players (2018-2023)
   Table 102. Breakdown of Neuroscience by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 103. Market Position of Players in Neuroscience, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 104. Head Office of Key Neuroscience Players
   Table 105. Neuroscience Market: Company Product Type Footprint
   Table 106. Neuroscience Market: Company Product Application Footprint
   Table 107. Neuroscience New Market Entrants and Barriers to Market Entry
   Table 108. Neuroscience Mergers, Acquisition, Agreements, and Collaborations
   Table 109. Global Neuroscience Consumption Value (USD Million) by Type (2018-2023)
   Table 110. Global Neuroscience Consumption Value Share by Type (2018-2023)
   Table 111. Global Neuroscience Consumption Value Forecast by Type (2024-2029)
   Table 112. Global Neuroscience Consumption Value by Application (2018-2023)
   Table 113. Global Neuroscience Consumption Value Forecast by Application (2024-2029)
   Table 114. North America Neuroscience Consumption Value by Type (2018-2023) & (USD Million)
   Table 115. North America Neuroscience Consumption Value by Type (2024-2029) & (USD Million)
   Table 116. North America Neuroscience Consumption Value by Application (2018-2023) & (USD Million)
   Table 117. North America Neuroscience Consumption Value by Application (2024-2029) & (USD Million)
   Table 118. North America Neuroscience Consumption Value by Country (2018-2023) & (USD Million)
   Table 119. North America Neuroscience Consumption Value by Country (2024-2029) & (USD Million)
   Table 120. Europe Neuroscience Consumption Value by Type (2018-2023) & (USD Million)
   Table 121. Europe Neuroscience Consumption Value by Type (2024-2029) & (USD Million)
   Table 122. Europe Neuroscience Consumption Value by Application (2018-2023) & (USD Million)
   Table 123. Europe Neuroscience Consumption Value by Application (2024-2029) & (USD Million)
   Table 124. Europe Neuroscience Consumption Value by Country (2018-2023) & (USD Million)
   Table 125. Europe Neuroscience Consumption Value by Country (2024-2029) & (USD Million)
   Table 126. Asia-Pacific Neuroscience Consumption Value by Type (2018-2023) & (USD Million)
   Table 127. Asia-Pacific Neuroscience Consumption Value by Type (2024-2029) & (USD Million)
   Table 128. Asia-Pacific Neuroscience Consumption Value by Application (2018-2023) & (USD Million)
   Table 129. Asia-Pacific Neuroscience Consumption Value by Application (2024-2029) & (USD Million)
   Table 130. Asia-Pacific Neuroscience Consumption Value by Region (2018-2023) & (USD Million)
   Table 131. Asia-Pacific Neuroscience Consumption Value by Region (2024-2029) & (USD Million)
   Table 132. South America Neuroscience Consumption Value by Type (2018-2023) & (USD Million)
   Table 133. South America Neuroscience Consumption Value by Type (2024-2029) & (USD Million)
   Table 134. South America Neuroscience Consumption Value by Application (2018-2023) & (USD Million)
   Table 135. South America Neuroscience Consumption Value by Application (2024-2029) & (USD Million)
   Table 136. South America Neuroscience Consumption Value by Country (2018-2023) & (USD Million)
   Table 137. South America Neuroscience Consumption Value by Country (2024-2029) & (USD Million)
   Table 138. Middle East & Africa Neuroscience Consumption Value by Type (2018-2023) & (USD Million)
   Table 139. Middle East & Africa Neuroscience Consumption Value by Type (2024-2029) & (USD Million)
   Table 140. Middle East & Africa Neuroscience Consumption Value by Application (2018-2023) & (USD Million)
   Table 141. Middle East & Africa Neuroscience Consumption Value by Application (2024-2029) & (USD Million)
   Table 142. Middle East & Africa Neuroscience Consumption Value by Country (2018-2023) & (USD Million)
   Table 143. Middle East & Africa Neuroscience Consumption Value by Country (2024-2029) & (USD Million)
   Table 144. Neuroscience Raw Material
   Table 145. Key Suppliers of Neuroscience Raw Materials

List of Figures

   Figure 1. Neuroscience Picture
   Figure 2. Global Neuroscience Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Neuroscience Consumption Value Market Share by Type in 2022
   Figure 4. Instrument and Consumables
   Figure 5. Software
   Figure 6. Others
   Figure 7. Global Neuroscience Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 8. Neuroscience Consumption Value Market Share by Application in 2022
   Figure 9. Academic Institutes Picture
   Figure 10. Hospital Picture
   Figure 11. Research Institutes Picture
   Figure 12. Others Picture
   Figure 13. Global Neuroscience Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 14. Global Neuroscience Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 15. Global Market Neuroscience Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 16. Global Neuroscience Consumption Value Market Share by Region (2018-2029)
   Figure 17. Global Neuroscience Consumption Value Market Share by Region in 2022
   Figure 18. North America Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 19. Europe Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 20. Asia-Pacific Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 21. South America Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 22. Middle East and Africa Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 23. Global Neuroscience Revenue Share by Players in 2022
   Figure 24. Neuroscience Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 25. Global Top 3 Players Neuroscience Market Share in 2022
   Figure 26. Global Top 6 Players Neuroscience Market Share in 2022
   Figure 27. Global Neuroscience Consumption Value Share by Type (2018-2023)
   Figure 28. Global Neuroscience Market Share Forecast by Type (2024-2029)
   Figure 29. Global Neuroscience Consumption Value Share by Application (2018-2023)
   Figure 30. Global Neuroscience Market Share Forecast by Application (2024-2029)
   Figure 31. North America Neuroscience Consumption Value Market Share by Type (2018-2029)
   Figure 32. North America Neuroscience Consumption Value Market Share by Application (2018-2029)
   Figure 33. North America Neuroscience Consumption Value Market Share by Country (2018-2029)
   Figure 34. United States Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 35. Canada Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 36. Mexico Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 37. Europe Neuroscience Consumption Value Market Share by Type (2018-2029)
   Figure 38. Europe Neuroscience Consumption Value Market Share by Application (2018-2029)
   Figure 39. Europe Neuroscience Consumption Value Market Share by Country (2018-2029)
   Figure 40. Germany Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 41. France Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 42. United Kingdom Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 43. Russia Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 44. Italy Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 45. Asia-Pacific Neuroscience Consumption Value Market Share by Type (2018-2029)
   Figure 46. Asia-Pacific Neuroscience Consumption Value Market Share by Application (2018-2029)
   Figure 47. Asia-Pacific Neuroscience Consumption Value Market Share by Region (2018-2029)
   Figure 48. China Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 49. Japan Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 50. South Korea Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 51. India Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 52. Southeast Asia Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 53. Australia Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 54. South America Neuroscience Consumption Value Market Share by Type (2018-2029)
   Figure 55. South America Neuroscience Consumption Value Market Share by Application (2018-2029)
   Figure 56. South America Neuroscience Consumption Value Market Share by Country (2018-2029)
   Figure 57. Brazil Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 58. Argentina Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 59. Middle East and Africa Neuroscience Consumption Value Market Share by Type (2018-2029)
   Figure 60. Middle East and Africa Neuroscience Consumption Value Market Share by Application (2018-2029)
   Figure 61. Middle East and Africa Neuroscience Consumption Value Market Share by Country (2018-2029)
   Figure 62. Turkey Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 63. Saudi Arabia Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 64. UAE Neuroscience Consumption Value (2018-2029) & (USD Million)
   Figure 65. Neuroscience Market Drivers
   Figure 66. Neuroscience Market Restraints
   Figure 67. Neuroscience Market Trends
   Figure 68. Porters Five Forces Analysis
   Figure 69. Manufacturing Cost Structure Analysis of Neuroscience in 2022
   Figure 70. Manufacturing Process Analysis of Neuroscience
   Figure 71. Neuroscience Industrial Chain
   Figure 72. Methodology
   Figure 73. Research Process and Data Source